vetmedin-ca1- pimobendan tablet, chewable
boehringer ingelheim animal health usa inc. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - vetmedin-ca1 (pimobendan) is indicated for the delay of onset of congestive heart failure in dogs with stage b2 preclinical myxomatous mitral valve disease (2019 acvim consensus statement1 ). stage b2 preclinical myxomatous mitral valve disease (mmvd) refers to dogs with asymptomatic mmvd that have a moderate or loud mitral murmur due to mitral regurgitation and cardiomegaly. do not administer vetmedin-ca1 in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. do not administer vetmedin-ca1 to dogs with stage a or b1 preclinical mmvd (2019 acvim consensus statement) due to the risk of cardiac pathology associated with exaggerated hemodynamic responses to vetmedin-ca1.
heartgard- ivermectin tablet
boehringer ingelheim animal health usa inc. - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - indication: for use in dogs to prevent canine heartworm disease. heartgard® prevents heartworm disease by eliminating the tissue stage of heartworm larvae (dirofilaria immitis ) for a month (30 days) after infection.
equioxx- firocoxib tablet, chewable
boehringer ingelheim animal health usa inc. - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - equioxx tablets are administered once daily for up to 14 days for the control of pain and inflammation associated with osteoarthritis in horses. horses with a hypersensitivity to firocoxib should not receive equioxx® tablets.
prascend- pergolide tablet
boehringer ingelheim animal health usa inc. - pergolide mesylate (unii: 55b9hqy616) (pergolide - unii:24mj822nz9) - pergolide 1 mg - prascend is contraindicated in horses with hypersensitivity to pergolide mesylate or other ergot derivatives.
heartgard- ivermectin tablet, chewable
boehringer ingelheim animal health usa inc. - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) -
aservo equihaler- ciclesonide spray, metered
boehringer ingelheim animal health usa inc. - ciclesonide (unii: s59502j185) (ciclesonide - unii:s59502j185) - do not use in horses with known hypersensitivity to ciclesonide or corticosteroids.
gastrogard- omeprazole paste
boehringer ingelheim animal health usa inc. - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - for treatment and prevention of recurrence of gastric ulcers in horses and foals 4 weeks of age and older.
equioxx- firocoxib paste
boehringer ingelheim animal health usa inc. - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - equioxx oral paste is administered for up to 14 days for the control of pain and inflammation associated with osteoarthritis in horses. horses with hypersensitivity to firocoxib should not receive equioxx oral paste.
marquis- ponazuril paste
boehringer ingelheim animal health usa inc. - ponazuril (unii: jpw84as66u) (ponazuril - unii:jpw84as66u) - marquis is indicated for the treatment of equine protozoal myeloencephalitis (epm) caused by sarcocystis neurona .
metacam- meloxicam suspension
boehringer ingelheim animal health usa inc. - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 0.15 g in 100 ml - metacam oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dogs with known hypersensitivity to meloxicam should not receive metacam oral suspension. do not use metacam oral suspension in cats. acute renal failure and death have been associated with the use of meloxicam in cats.